↓ Skip to main content

Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland

Overview of attention for article published in Regulatory Toxicology & Pharmacology: RTP, August 2017
Altmetric Badge

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland
Published in
Regulatory Toxicology & Pharmacology: RTP, August 2017
DOI 10.1016/j.yrtph.2017.06.013
Pubmed ID
Authors

Joan O'Callaghan, Margaret Bermingham, Maurice Leonard, Frank Hallinan, J. Michael Morris, Una Moore, Brendan T. Griffin

Abstract

Increasing numbers of biosimilar medicines are becoming available. The objective of this survey was to assess awareness of and attitudes to biosimilars amongst physicians (medical specialists and General Practitioners (GPs)) and community pharmacists in Ireland. Physicians were invited to complete an online questionnaire during April and May 2016. Community pharmacists received a postal questionnaire in August 2015 Responses from 102 medical specialists, 253 GPs and 125 community pharmacists were analysed. The majority of medical specialists (85%) and pharmacists (77%) claimed to be either very familiar or familiar with the term biosimilar, whereas many GPs (60%) were unable to define or had never heard of the term. One in five (21%) healthcare professionals responded that biosimilars were the same as generic medicines. The majority of medical specialists opposed pharmacist-led substitution of biological medicines but some thought it could be appropriate if agreed with the clinician in advance. Medical specialists who prescribe biosimilars (n = 43) were more likely to do so on treatment initiation (67%), than switch a patient from an originator medicine to a biosimilar (28%). The findings will aid the design of educational initiatives for healthcare professionals and highlight attitudes of healthcare professionals to biosimilars, so informing regulators, policy makers and industry.

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 98 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 21%
Student > Ph. D. Student 11 11%
Researcher 9 9%
Student > Bachelor 9 9%
Other 8 8%
Other 14 14%
Unknown 26 27%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 33 34%
Medicine and Dentistry 10 10%
Nursing and Health Professions 7 7%
Economics, Econometrics and Finance 5 5%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 9 9%
Unknown 31 32%